Measuring health‐related quality of life in adolescent and young adult cancer survivors with the National Institutes of Health Patient‐Reported Outcomes Measurement Information System®: Comparing adolescent, emerging adult, and young adult survivor perspectives is a research paper published in Psycho-Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 56 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Feinberg School of Medicine
Grant: Pilot funding, no award number
National Cancer Institute
Grant: R01CA218398
National Institutes of Health
Grant: 1R01CA218398-01
Optimizing health related quality of life measurement in adolescent and young adult oncology: A PROMISing solution
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
Additional file 1 of Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
Additional file 2 of Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
Additional file 2 of Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
Additional file 3 of Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
Additional file 3 of Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant